Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

ClinicalTrials.gov ID: NCT00583986

Public ClinicalTrials.gov record NCT00583986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Determine the Reliability of a Top Mount Actuation Indicator When Used With Levalbuterol Tartrate HFA MDI in Adult and Pediatric Subjects With Asthma or Chronic Obstructive Pulmonary Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to investigate the reliability, ruggedness and safety of the top mounted actuation indicator (TMAI) when used with Levalbuterol HFA MDI.

Study identification

NCT ID: NCT00583986
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Enrollment: 150 participants

Conditions and interventions

Conditions

Interventions

Levalbuterol HFA MDI with top mounted actuation indicator Drug

Drug

Eligibility (public fields only)

Age range: 4 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2005 (Type not available)
Primary completion: Jan 2006 (Actual)
Completion: Mar 2006 (Actual)
Last update posted: Feb 22, 2012

2005 – 2006

United States locations

U.S. sites: 26
U.S. states: 13
U.S. cities: 26

Facility	City	State	ZIP	Site status
Not listed	Encinatas	California	92024	—
Not listed	Huntington Beach	California	92647	—
Not listed	Mesa	California	92626	—
Not listed	Orange County	California	92868	—
Not listed	Riverside	California	92506	—
Not listed	San Diego	California	92120	—
Not listed	San Jose	California	95128	—
Not listed	Viejo	California	92691	—
Not listed	Walnut Creek	California	94596	—
Not listed	Tamarac	Florida	33321	—
Not listed	Russells Mills	Massachusetts	02747	—
Not listed	Commack	New York	11725	—
Not listed	Rochester	New York	14618	—
Not listed	Elizabeth City	North Carolina	27909	—
Not listed	Oklahoma City	Oklahoma	73120	—
Not listed	Medford	Oregon	97504	—
Not listed	Portland	Oregon	97213	—
Not listed	Philadelphia	Pennsylvania	19115	—
Not listed	Simpsonville	South Carolina	29681	—
Not listed	Chattanooga	Tennessee	37421	—
Not listed	Austin	Texas	78750	—
Not listed	Braunfels	Texas	78130	—
Not listed	San Antonio	Texas	78229	—
Not listed	Burke	Virginia	22015	—
Not listed	Richmond	Virginia	23225	—
Not listed	Morgantown	West Virginia	26505	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00583986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 22, 2012 · Synced Oct 21, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00583986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →